FDA approves first nasal spray diuretic for heart, liver and kidney disease

Medical Tech

Published on:

Source: New Atlas | New TechBy: Bronwyn ThompsonDate: 09/15/2025, 9:03:00 PM
The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than a million hospitalizations each year. Enbumyst, a…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.
SubscribeSign in